2025-03-01
2024-05-19
| Summary | |
|---|---|
| Cancer Type | Lung Cancer |
| Grade | NA |
| Stage | NA |
| Ethnicity | Asian |
| Gender | F |
| Age | 65 |
| Pathology Diagnosis | Poorly differentiated adenocarcinoma of lung, tumor mass: 4.5 x 4 x 2.5cm. Regional LN: hilum of lung LN (0/1), superior mediastinal LN (3/9), LN of inferior parapulmonary vein (1/1), inferior carina of trachea LN (0/9). IHC results: CK8/18(+),CK7(+++), CK34(+), CK5/6(-), K167(+)10%, CgA(-), HMB45(-), ERCC-1(-), VECFR(++), TP(-), Her-2(+), Syn(-), TTF(++), BGFR(++), B-microtubulin(+++), P53(++), CD34(blood vessel +). |
| Biopsy Site | primary |
| Treatment History | NA |
| Pathology QC | Poorly differentiated adenocarcinoma (P2, P4); IHC (P5): TTF1(+), CDX2(-), CK7(3+), CK20(-). |
| Special Features | NA |
| Mouse Strain | Balb/c nu |
| TMA | TMA-HP-LU-017 |
| Viral Status in PDX | NA |
| Available In | CB_CN |
| RNA Seq | P5 |
| Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy